Search results for "Paroxysmal"

showing 10 items of 64 documents

Suppressive Efficacy by a Commercially Available Blue Lens on PPR in 610 Photosensitive Epilepsy Patients

2006

Purpose Photosensitivity can represent a serious problem in epilepsy patients, also because pharmacologic treatment is often ineffective. Nonpharmacologic treatment using blue sunglasses is effective and safe in controlling photosensitivity, but large series of patients have never been studied. Methods This multicenter study was conducted in 12 epilepsy centers in northern, central, southern, and insular Italy. A commercially available lens, named Z1, obtained in a previous trial, was used to test consecutively enrolled pediatric and adult epilepsy patients with photosensitivity. Only type 4 photosensitivity (photoparoxysmal response, PPR) was considered in the study. A standardized method …

EPILEPSY-PHOTOSENSITIVE-BLUE GLASSES-NONPHARMACOLOGICAdultMalemedicine.medical_specialtyAdolescentEpilepsy ReflexPharmacological treatmentCentral nervous system diseaseEpilepsyPhotosensitive epilepsyInternal medicineFemale patientmedicineHumansPractice Patterns Physicians'ChildAgedbusiness.industryVideotape RecordingLarge seriesElectroencephalographyMiddle Agedmedicine.diseaseTREATMENT-PHOTOPAROXYSMAL RESPONSE-PPRSurgeryClinical trialTreatment OutcomeItalyNeurologyMulticenter studyChild PreschoolAnticonvulsantsFemaleNeurology (clinical)PHOTOSENSITIVEEye Protective DevicesbusinessColor PerceptionPhotic StimulationEpilepsia
researchProduct

Vertigo in childhood: A methodological approach

2012

Children complaints dizziness merit meticulous evaluation to differentially diagnose a vestibular disease. A syndrome mimicking certain classic signs and symptoms of adult vestibular disorders may be presents in children, such as benign paroxysmal positional vertigo, usually associated with aging. Benign paroxysmal vertigo, in which migraine is a manifestation, with sudden onset of dizziness is a rare peripheral vestibular disorder that is commonly ignored or misdiagnosed. This review covers the development of the diagnosis, evaluation and treatment approaches of vertigo of childhood, a valid support for physician that approach dizzy children (Ref. 25). Full Text in PDF www.elis.sk.

Economics and EconometricsPediatricsmedicine.medical_specialtyBenign paroxysmal positional vertigoVestibular disordersSigns and symptomsDizzinessPeripheral vestibular disorderVertigootorhinolaryngologic diseasesMaterials ChemistryMedia TechnologymedicineHumansBenign Paroxysmal Positional VertigoChildVestibular systemPediatricbiologyBenign paroxysmal vertigobusiness.industryForestrymedicine.diseasebiology.organism_classificationChildhoodMigraineVertigosense organsbusinessSudden onset
researchProduct

Assisting Electrophysiological Substrate Quantification in Atrial Fibrillation Ablation

2019

[EN] Catheter ablation (CA) is the most popular treatment of atrial fibrillation (AF) with good results in paroxysmal AF, while its efficiency is significantly reduced in persistent AF. With the equipment used for CA strongly depending on electro-gram (EGM) fractionation quantification, the use of a reliable fractionation estimator is crucial to reduce the high recurrence rates in persistent AF. This work introduces a non-linear EGM fractionation quantification technique, which is based on coarse-grained correlation dimension (CGCD) computed over epochs of 1 second. Recordings were firstly normalized, denoised and lowpass filtered. The final CGCD value was calculated by the median CGCD valu…

Electrogram fractionationSubstrate mappingbusiness.industrymedicine.medical_treatment0206 medical engineeringCatheter ablationAtrial fibrillation02 engineering and technology030204 cardiovascular system & hematologyAblationmedicine.diseaseCorrelation dimension020601 biomedical engineeringAtrial fibrillationTECNOLOGIA ELECTRONICA03 medical and health sciencesElectrophysiology0302 clinical medicineSettore ING-INF/06 - Bioingegneria Elettronica E InformaticamedicineCatheter ablationNuclear medicinebusinessParoxysmal AF
researchProduct

Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results fro…

2019

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, potentially fatal disorder of haematopoietic stem cells caused by mutations in an X-linked gene called phosphatidylinositol glycan class A, characterised by intravascular haemolysis, bone marrow failure and thrombotic events. The disease can occur at any age, although preferentially it affects young adults; its estimated prevalence is about 1/500,000 [1]. Clinical symptoms are variable and can include haemolytic anaemia, moderate to severe impairment of haematopoiesis and, in approximately 40% of patients, thrombosis of the vessels of the abdomen, brain and skin [2]. Rare, atypical site thrombosis of the splanchnic veins or cerebral sinu…

First episodemedicine.medical_specialtybusiness.industryCross-sectional studyHemoglobinuria ParoxysmalThrombosisHematologymedicine.diseasePhenotypePeripheralVein thrombosisVenous thrombosisCross-Sectional StudiesPhenotypeInternal medicinemedicineCardiologyHumansParoxysmal nocturnal haemoglobinuriaRisk factorbusinessCerebral sinus venous thrombosisPNHRisk factorScreeningVenous thrombosis
researchProduct

Vertigo and osteoporosis: The correlation between nutritional intake of Vitamin D and incidence of recurring benign paroxysmal positional vertigo in …

2018

Introduction: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral cause of vertigo. It can be defined as transient vertigo induced by rapid changes in head position associated with a characteristic paroxysmal positional nystagmus. The aim of this study is to evaluate the association between the serum calcium and Vitamin D levels in osteoporotic patients affected by recurrent BPPV. Materials and Methods: Calcium and 25-hydroxy-Vitamin D levels were evaluated in peripheral venous serum samples of 40 BPPV patients. Results: The reduction of serum Vitamin D levels is present in 16 of BPPV patients with recurrence. After nutritional intake of Vitamin D there was a decline o…

Hypovitaminosis DBenign paroxysmal positional vertigoVitamin D
researchProduct

Corrigendum to “A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo” [Au…

2014

Alessandro De Stefano *, Francesco Dispenza , Hamlet Suarez , Nicolas Perez-Fernandez , Raquel Manrique-Huarte , Jae Ho Ban , Min-Beom Kim , Michael Strupp , Katharina Feil , Carlos A. Oliveira , Andres L. Sampaio , Mercedes F.S. Araujo , Fayez Bahmad Jr., Mauricio M. Gananca , Fernando F. Gananca , Ricardo Dorigueto , Hyung Lee , Gautham Kulamarva , Navneet Mathur , Pamela Di Giovanni , Anna Grazia Petrucci , Tommaso Staniscia , Leonardo Citraro , Adelchi Croce a

Larynxmedicine.medical_specialtyBenign paroxysmal positional vertigomedicine.anatomical_structureOtorhinolaryngologybusiness.industryGeneral surgerymedicineSurgeryGeneral Medicinemedicine.diseasebusinessSurgeryAuris Nasus Larynx
researchProduct

De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurologi…

2019

Abstract KCNMA1 encodes the large-conductance Ca2+- and voltage-activated K+ (BK) potassium channel α-subunit, and pathogenic gain-of-function variants in this gene have been associated with a dominant form of generalized epilepsy and paroxysmal dyskinesia. Here, we genetically and functionally characterize eight novel loss-of-function (LoF) variants of KCNMA1. Genome or exome sequencing and the participation in the international Matchmaker Exchange effort allowed for the identification of novel KCNMA1 variants. Patch clamping was used to assess functionality of mutant BK channels. The KCNMA1 variants p.(Ser351Tyr), p.(Gly356Arg), p.(Gly375Arg), p.(Asn449fs) and p.(Ile663Val) abolished the …

MaleAtaxiaGenotypeDevelopmental DisabilitiesMutation MissenseBiology03 medical and health sciences0302 clinical medicineNeurodevelopmental disorderProtein DomainsLoss of Function MutationGeneticsmedicineHumansMissense mutationAbnormalities MultipleGenetic Predisposition to DiseaseProtein Interaction Domains and MotifsAlleleLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMolecular BiologyAllelesGenetic Association StudiesGenetics (clinical)Loss functionExome sequencing030304 developmental biologyGenetics0303 health sciencesInfant NewbornGeneral MedicineParoxysmal dyskinesiamedicine.diseaseElectrophysiological PhenomenaPedigreePhenotypeAmino Acid SubstitutionSpeech delayFemaleGeneral Articlemedicine.symptom030217 neurology & neurosurgeryHuman Molecular Genetics
researchProduct

Canal switch and re-entry phenomenon in benign paroxysmal positional vertigo: difference between immediate and delayed occurrence

2014

Studio prospettico ideato per la valutazione delle differenze tra la conversione canalare o il rientro degli otoliti nei canali semicircolari successivo alle manovre terapeutiche nei pazienti affetti da VPPB. Sono stati valutati 196 pazienti affetti da VPPB, 127 dei quali corrispondevano ai criteri di inclusione. L’età media dei pazienti era di 54.74 anni. Il canale orizzontale è stato coinvolto in 30 casi e il canale posteriore in 97 pazienti. I pazienti con sordità neurosensoriale presentavano forme ricorrenti di VPPB, rispetto a quelli con udito normale. L’immediato rientro canalare è stato diagnosticato in 3 pazienti con VPPB del canale laterale, tutti con nistagmo geotropo. 7 pazienti …

MaleBenign paroxysmal positional vertigo; Canal conversion; Dizziness; Vertigo; canal switchTime FactorsDizzinecanal switchMiddle AgedSettore MED/42 - Igiene Generale E ApplicataCanal conversionDizzinessVestibologyOtolithic Membraneotorhinolaryngologic diseasesVertigoHumansFemalesense organsProspective StudiesBenign paroxysmal positional vertigo
researchProduct

Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutat…

2008

Monocarboxylate transporter 8 (MCT8 or SLC16A2) is important for the neuronal uptake of triiodothyronine (T3) in its function as a specific and active transporter of thyroid hormones across the cell membrane, thus being essential for human brain development. We report on a German male with Allan-Herndon-Dudley syndrome presenting with severe intellectual and motor disability, paroxysmal dyskinesia combined with truncal muscular hypotonia, and peripheral muscular hypertonia at his current age of 9 years. Additionally, the patient has a lesion in the left putamen region revealed by magnetic resonance imaging and elevated serum T3 levels. The male appeared to have a hemizygous mutation (R271H)…

MaleMonocarboxylic Acid Transportersmedicine.medical_specialtyDevelopmental DisabilitiesDNA Mutational AnalysisEnzyme-Linked Immunosorbent AssayGene mutationArginineLesionDevelopmental NeuroscienceChoreaInternal medicineIntellectual DisabilitymedicineHumansHistidineChildMonocarboxylate transporterAllan–Herndon–Dudley syndromeTriiodothyroninebiologyMuscular hypotoniaSymportersParoxysmal dyskinesiamedicine.diseaseMagnetic Resonance ImagingEndocrinologyPediatrics Perinatology and Child HealthMutationbiology.proteinHypertoniaTriiodothyronineNeurology (clinical)medicine.symptomDevelopmental medicine and child neurology
researchProduct

Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review.

2012

MaleMutationHemoglobinuria ParoxysmalHumansMembrane ProteinsFemaleThrombosisReviewEPNSettore MED/15 - Malattie Del Sangue
researchProduct